Prognostic Relationship Between the Cachexia Index and Osteopenia in Patients With Pancreatic Cancer
Anticancer Research · 2025
DOI: 10.21873/anticanres.17509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Teruhisa Sakamoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, Faculty of Medicine, Tottori University, Yonago, Japan tesakamo@tottori-u.…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Cachexia, Bone Diseases, Metabolic. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, Faculty of Medicine, Tottori University, Yonago, Japan tesakamo@tottori-u.ac.jp.
- Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, Faculty of Medicine, Tottori University, Yonago, Japan.
Zitieren
APA
Sakamoto, T., Kishino, M., Murakami, Y., Miyatani, K., Shishido, Y., Kihara, K., Matsunaga, T., Yamamoto, M., Tokuyasu, N., & Fujiwara, Y. (2025). Prognostic Relationship Between the Cachexia Index and Osteopenia in Patients With Pancreatic Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17509
Vancouver
Sakamoto T, Kishino M, Murakami Y, Miyatani K, Shishido Y, Kihara K, et al. Prognostic Relationship Between the Cachexia Index and Osteopenia in Patients With Pancreatic Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17509
BibTeX
@article{Sakamoto2025,
author = {Sakamoto, Teruhisa and Kishino, Mikiya and Murakami, Yuki and Miyatani, Kozo and Shishido, Yuji and Kihara, Kyoichi and Matsunaga, Tomoyuki and Yamamoto, Manabu and Tokuyasu, Naruo and Fujiwara, Yoshiyuki},
title = {Prognostic Relationship Between the Cachexia Index and Osteopenia in Patients With Pancreatic Cancer},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17509}
}
EUVIMED